Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias

Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on...

Full description

Saved in:
Bibliographic Details
Published inJournal of lipid research Vol. 17; no. 2; pp. 125 - 131
Main Authors Dawson, G, Kruski, A W, Scanu, A M
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.1976
Elsevier
Subjects
Online AccessGet full text
ISSN0022-2275
1539-7262
DOI10.1016/S0022-2275(20)36996-0

Cover

Loading…
Abstract Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum from normal subjects was twice as high in very low density lipoprotein (VLDL) (d < than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined.
AbstractList Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum normal subjects was twice as high in very low density lipoprotein (VLDL) (d less than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined.Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum normal subjects was twice as high in very low density lipoprotein (VLDL) (d less than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined.
Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum normal subjects was twice as high in very low density lipoprotein (VLDL) (d less than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined.
Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human subjects and patients with dyslipoproteinemia and found to be exclusively associated with the various classes of serum lipoproteins. Based on a unit weight of lipoprotein protein, the total amount of GSL in serum from normal subjects was twice as high in very low density lipoprotein (VLDL) (d < than 1.006 g/ml) and low density lipoprotein (LDL) (d 1.019-1.063 g/ml) as in high density lipoproteins HDL2 (d 1.063-1.125 g/ml) or HDL3 (d 1.125-1.21 g/ml). In abetalipoproteinemia the levels of serum GSL were slightly reduced when compared to normal serum and were all found in the only existing lipoprotein, HDL; this contained 2-3 moles of GSL/ mole of lipoprotein as compared to 0.5 GSL/mole in normal HDL. In hypobetalipoproteinemia and Tangier disease, the serum glycosphingolipids were 10 to 30% reduced in concentration compared to the 75% reduction in other lipids, and were again found to be associated only with the serum lipoproteins. The relative proportions of GSL did not vary substantially in the normo- and hypolipidemic subjects studied. Only in patients with homozygous familial hypercholesterolemia was there a significant (3-4-fold) elevation of all of the five GSL species and this elevation correlated well with that of the circulating cholesterol and LDL. On a molar basis the LDL of these patients contained the same amount of GSL as normal subjects (5 moles GSL/mole protein). It is concluded that: (1) glycosphingolipids are associated only with the major lipoprotein classes in both normal and dyslipoproteinemic serum; (2) the relative proportions of the five glycosphingolipids are not significantly affected by dyslipoproteinemia; (3) only in severe hypolipoproteinemia do the remaining serum lipoproteins carry a complement of glycosphingolipids greater than normal. Although our results establish that glycosphingolipids are intimately associated with serum lipoproteins, the mode of association or the structural and functional significance of such an association remains undetermined.
Author Kruski, A W
Dawson, G
Scanu, A M
Author_xml – sequence: 1
  givenname: G
  surname: Dawson
  fullname: Dawson, G
  organization: Departments of Pediatrics, Biochemistry and Medicine, University of Chicago, Pritzker School of Medicine and the Franklin McLean Memorial Research Institute, Chicago, Illinois 60637
– sequence: 2
  givenname: A W
  surname: Kruski
  fullname: Kruski, A W
  organization: Departments of Pediatrics, Biochemistry and Medicine, University of Chicago, Pritzker School of Medicine and the Franklin McLean Memorial Research Institute, Chicago, Illinois 60637
– sequence: 3
  givenname: A M
  surname: Scanu
  fullname: Scanu, A M
  organization: Departments of Pediatrics, Biochemistry and Medicine, University of Chicago, Pritzker School of Medicine and the Franklin McLean Memorial Research Institute, Chicago, Illinois 60637
BackLink https://www.ncbi.nlm.nih.gov/pubmed/178813$$D View this record in MEDLINE/PubMed
BookMark eNqFkUuPFCEUhYkZHz2j_0ATVkYXpUBBQWUWxoyvSSZxoa4JDbe66VRBCZSml_5z6e7JmLiZFXA559zkfOfoLMQACL2g5A0ltHv7jRDGGsakeMXI67br-64hD9CKirZvJOvYGVrdSZ6g85x3hFDOO_oYPaJSKdqu0J8PPpfk10vxMeA44M24tzHPWx82cfSzdxn7gMsWcIa0TLjO4pxiAR_yQR9imsyIt8tkAs7Lege2ZGyCw7MpHkJ9_PZli7f7OTbHeb1BOkbD5E1-ih4OZszw7Pa8QD8-ffx-9aW5-fr5-ur9TWM5ZaQRkhPHlaCD5JIxrqzjnVOSuLYdhGNqkNYaagRZCyuJATZI0w22VdKQoWftBbo-5bpodnpOfjJpr6Px-jiIaaNNKt6OoFkv6kpwhJqeq5YqCgJqrbLrnOGDqlkvT1m1iZ8L5KInny2MowkQl6xVy5lghFbh81vhsp7A3a091V-_xenbpphzguGfgOgDZH2ErA8ENSP6CFmT6rv8z2d9MQeEJRk_3ut-d3JDrfuXh6SzraQsOJ8qvdqHvyfhL7VuwgI
CitedBy_id crossref_primary_10_1096_fj_08_117150
crossref_primary_10_1155_2018_9025841
crossref_primary_10_1073_pnas_2120489119
crossref_primary_10_1007_s11892_009_0085_7
crossref_primary_10_1016_0005_2760_85_90273_5
crossref_primary_10_1016_S0021_9258_18_35871_X
crossref_primary_10_1517_17530059_2013_846322
crossref_primary_10_1128_JCM_39_2_798_800_2001
crossref_primary_10_1016_S0021_9258_18_37665_8
crossref_primary_10_1016_j_bbalip_2010_11_003
crossref_primary_10_1016_S0021_9258_19_70102_1
crossref_primary_10_1038_35089558
crossref_primary_10_1042_CS20090452
crossref_primary_10_1016_0003_9861_85_90179_1
crossref_primary_10_1016_j_tcm_2005_08_005
crossref_primary_10_1056_NEJM197704142961521
crossref_primary_10_1007_BF00731466
crossref_primary_10_1007_s00394_015_0879_0
crossref_primary_10_1016_j_atherosclerosis_2012_08_041
crossref_primary_10_1016_j_isci_2024_111051
crossref_primary_10_1016_j_jacl_2013_08_001
crossref_primary_10_1016_0005_2760_82_90112_6
crossref_primary_10_1586_14779072_3_6_1071
crossref_primary_10_1016_S0021_9258_19_68819_8
crossref_primary_10_1194_jlr_M006759
crossref_primary_10_1016_j_cca_2013_12_001
crossref_primary_10_1016_j_tcm_2007_02_006
crossref_primary_10_1016_S0021_9258_18_33664_0
crossref_primary_10_1006_bbrc_2002_6356
crossref_primary_10_1007_BF01311096
crossref_primary_10_1194_jlr_D062083
crossref_primary_10_3390_diseases6030082
crossref_primary_10_1007_s40620_015_0193_1
crossref_primary_10_1194_jlr_R036095
crossref_primary_10_1016_0005_2760_92_90043_U
crossref_primary_10_1016_S0022_2275_20_38394_2
crossref_primary_10_1016_S0021_9258_19_68820_4
crossref_primary_10_1182_blood_V97_7_1907
crossref_primary_10_1002_psp4_12506
crossref_primary_10_1016_S0022_2275_20_37285_0
crossref_primary_10_1194_jlr_M087502
crossref_primary_10_1111_j_1399_0004_1984_tb00799_x
crossref_primary_10_1016_0009_8981_83_90230_9
crossref_primary_10_1161_CIRCULATIONAHA_114_010006
crossref_primary_10_1016_0005_2760_85_90082_7
crossref_primary_10_1016_0161_5890_84_90118_4
crossref_primary_10_1016_S0021_9258_19_81070_0
crossref_primary_10_1111_j_1432_1033_1978_tb12363_x
crossref_primary_10_1161_ATVBAHA_109_201673
crossref_primary_10_1016_0005_2744_78_90359_5
crossref_primary_10_1016_0021_9150_92_90235_9
crossref_primary_10_1074_jbc_RA118_005876
crossref_primary_10_1161_01_ATV_18_10_1523
crossref_primary_10_1016_0009_8981_77_90511_3
crossref_primary_10_1111_j_1471_4159_1989_tb09199_x
crossref_primary_10_1002_1531_8249_200002_47_2_229__AID_ANA13_3_0_CO_2_T
crossref_primary_10_1016_0014_5793_96_00392_4
crossref_primary_10_1161_CIRCULATIONAHA_113_007559
crossref_primary_10_1016_j_atherosclerosis_2007_09_018
crossref_primary_10_1016_0021_9150_80_90081_7
crossref_primary_10_3390_nu16193296
crossref_primary_10_1074_jbc_M115_659110
crossref_primary_10_1016_j_tem_2017_03_005
crossref_primary_10_1002_rth2_12017
crossref_primary_10_2217_clp_12_14
crossref_primary_10_1073_pnas_1415357111
crossref_primary_10_1016_0005_2795_81_90250_6
crossref_primary_10_1111_j_1423_0410_1981_tb00665_x
crossref_primary_10_1006_abio_1998_2966
crossref_primary_10_1016_S0022_2275_20_39890_4
crossref_primary_10_1007_BF02534789
crossref_primary_10_1128_CVI_00060_08
crossref_primary_10_1111_j_1471_4159_1988_tb01049_x
crossref_primary_10_1016_j_bbrc_2020_02_104
crossref_primary_10_1016_0005_2760_78_90158_3
crossref_primary_10_1194_jlr_E800005_JLR200
crossref_primary_10_1016_S0165_5728_99_00203_9
crossref_primary_10_5551_jat_13_281
crossref_primary_10_1016_S0022_2275_20_40115_4
crossref_primary_10_3389_fcell_2021_658995
crossref_primary_10_1016_S0021_9258_18_67044_9
crossref_primary_10_1016_S0022_2275_20_41686_4
crossref_primary_10_1016_0304_4165_79_90391_X
crossref_primary_10_1016_S0022_2275_20_38115_3
crossref_primary_10_1016_j_biomaterials_2015_06_001
Cites_doi 10.1172/JCI107578
10.1016/S0022-2275(20)39414-1
10.1016/S0021-9258(18)63406-4
10.1016/0006-291X(74)90426-4
10.1016/0003-2697(71)90247-8
10.1042/bj1040340
10.1172/JCI107333
10.1056/NEJM196702022760507
10.1016/S0022-2275(20)38884-2
10.1016/S0021-9258(19)52451-6
10.1212/WNL.24.11.1051
10.1016/0006-3002(63)90773-X
10.1016/S0022-2275(20)42667-7
10.1016/S0021-9258(18)70226-3
10.1126/science.164.3879.553
10.1016/S0065-2423(08)60345-5
10.1016/0009-8981(68)90135-6
10.1016/S0021-9258(18)64849-5
10.1016/0005-2760(70)90159-1
10.1016/S0022-2275(20)39374-3
ContentType Journal Article
Copyright 1976 © 1976 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
Copyright_xml – notice: 1976 © 1976 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1016/S0022-2275(20)36996-0
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1539-7262
EndPage 131
ExternalDocumentID oai_doaj_org_article_295120ed01a9483181e5e153766da4f8
178813
10_1016_S0022_2275_20_36996_0
S0022227520369960
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GroupedDBID ---
-~X
.55
.GJ
0SF
0VX
18M
29K
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6I.
AAEDW
AAFTH
AAFWJ
AAXUO
AAYOK
ABCQX
ABOCM
ACCCW
ACGFO
ACKIV
ACNCT
ACPRK
ADBBV
AENEX
AEXQZ
AFFNX
AFOSN
AFPKN
AHPSJ
AI.
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BTFSW
C1A
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
F5P
FDB
FRP
GROUPED_DOAJ
GX1
H13
HH5
HYE
H~9
J5H
KQ8
L7B
MVM
OK1
P2P
RHF
RHI
ROL
RPM
TBC
TR2
TWZ
VH1
W8F
WH7
WOQ
X7M
XFK
YHG
YKV
ZA5
ZGI
ZXP
~KM
0R~
AALRI
AAYWO
AAYXX
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AIGII
AITUG
AKBMS
AKRWK
AKYEP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4120-5740d4851f7472248cd46d870d33f5d28f7cca1a50b5c70ae2f7a6fc387a0f923
IEDL.DBID DOA
ISSN 0022-2275
IngestDate Wed Aug 27 01:29:22 EDT 2025
Fri Jul 11 01:11:14 EDT 2025
Thu Jan 02 22:56:50 EST 2025
Tue Jul 01 01:14:45 EDT 2025
Thu Apr 24 23:05:50 EDT 2025
Fri Feb 23 02:45:54 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords gas-liquid chromatography
mixed hyperlipoproteinemias
abetalipoproteinemia
hypobetalipoproteinemia
familial hypercholesterolemia
Tangier disease
serum glycosphingolipids
Language English
License This is an open access article under the CC BY license.
http://creativecommons.org/licenses/by/4.0
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4120-5740d4851f7472248cd46d870d33f5d28f7cca1a50b5c70ae2f7a6fc387a0f923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/295120ed01a9483181e5e153766da4f8
PMID 178813
PQID 83425201
PQPubID 23479
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_295120ed01a9483181e5e153766da4f8
proquest_miscellaneous_83425201
pubmed_primary_178813
crossref_primary_10_1016_S0022_2275_20_36996_0
crossref_citationtrail_10_1016_S0022_2275_20_36996_0
elsevier_sciencedirect_doi_10_1016_S0022_2275_20_36996_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1976-Mar
PublicationDateYYYYMMDD 1976-03-01
PublicationDate_xml – month: 03
  year: 1976
  text: 1976-Mar
PublicationDecade 1970
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of lipid research
PublicationTitleAlternate J Lipid Res
PublicationYear 1976
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Franey, Amader (bib16) 1968; 21
Scanu (bib25) 1973
Rapport, Graf (bib22) 1969; 13
Sweeley, Dawson (bib4) 1969
Bartlett (bib20) 1959; 234
Vance, Sweeley (bib2) 1967; 8
Marcus, Cass (bib6) 1969; 164
Aggerbeck, McMahon, Scanu (bib11) 1974; 24
Van Handel, Zilversmit (bib17) 1957; 50
Hazzard, Goldstein, Schrott, Motulsky, Berman (bib12) 1973; 52
Yu, Ledeen (bib5) 1972; 13
Naiki, Marcus (bib23) 1974; 60
Tao, Sweeley (bib3) 1970; 218
Skipski, Barclay, Barclay, Fetzer, Good, Archibald (bib8) 1967; 103
Fredrickson, Levy, Lees (bib13) 1967; 276
Folch, Lees, Stanley (bib18) 1957; 226
Scanu, Edelstein (bib15) 1971; 44
Dawson (bib19) 1972; 13
Dawson, Sweeley (bib9) 1970; 245
Scanu, Aggerbeck, Kruski, Lim, Kayden (bib10) 1974; 53
Scanu, Ritter (bib14) 1973; 16
Vance, Krivit, Sweeley (bib7) 1969; 10
Scanu, Kruski (bib24) 1975
Svennerholm, Svennerholm (bib1) 1963; 70
Lowry, Rosebrough, Farr, Randall (bib21) 1951; 193
Naiki (10.1016/S0022-2275(20)36996-0_bib23) 1974; 60
Scanu (10.1016/S0022-2275(20)36996-0_bib25) 1973
Aggerbeck (10.1016/S0022-2275(20)36996-0_bib11) 1974; 24
Skipski (10.1016/S0022-2275(20)36996-0_bib8) 1967; 103
Vance (10.1016/S0022-2275(20)36996-0_bib7) 1969; 10
Marcus (10.1016/S0022-2275(20)36996-0_bib6) 1969; 164
Rapport (10.1016/S0022-2275(20)36996-0_bib22) 1969; 13
Hazzard (10.1016/S0022-2275(20)36996-0_bib12) 1973; 52
Lowry (10.1016/S0022-2275(20)36996-0_bib21) 1951; 193
Scanu (10.1016/S0022-2275(20)36996-0_bib10) 1974; 53
Van Handel (10.1016/S0022-2275(20)36996-0_bib17) 1957; 50
Tao (10.1016/S0022-2275(20)36996-0_bib3) 1970; 218
Yu (10.1016/S0022-2275(20)36996-0_bib5) 1972; 13
Fredrickson (10.1016/S0022-2275(20)36996-0_bib13) 1967; 276
Scanu (10.1016/S0022-2275(20)36996-0_bib14) 1973; 16
Dawson (10.1016/S0022-2275(20)36996-0_bib9) 1970; 245
Dawson (10.1016/S0022-2275(20)36996-0_bib19) 1972; 13
Scanu (10.1016/S0022-2275(20)36996-0_bib24) 1975
Scanu (10.1016/S0022-2275(20)36996-0_bib15) 1971; 44
Folch (10.1016/S0022-2275(20)36996-0_bib18) 1957; 226
Sweeley (10.1016/S0022-2275(20)36996-0_bib4) 1969
Franey (10.1016/S0022-2275(20)36996-0_bib16) 1968; 21
Vance (10.1016/S0022-2275(20)36996-0_bib2) 1967; 8
Bartlett (10.1016/S0022-2275(20)36996-0_bib20) 1959; 234
Svennerholm (10.1016/S0022-2275(20)36996-0_bib1) 1963; 70
References_xml – volume: 234
  start-page: 466
  year: 1959
  end-page: 468
  ident: bib20
  article-title: Phosphorus assay in column chromatography
  publication-title: J. Biol. Chem.
– volume: 8
  start-page: 621
  year: 1967
  end-page: 630
  ident: bib2
  article-title: Quantitative determination of the neutral glycosylceramides in human blood
  publication-title: J. Lipid Res.
– volume: 21
  start-page: 255
  year: 1968
  end-page: 266
  ident: bib16
  article-title: Serum cholesterol measurement based on ethanol extraction of ferric chloride sulfuric acid
  publication-title: Clin. Chim. Acta.
– volume: 226
  start-page: 497
  year: 1957
  end-page: 509
  ident: bib18
  article-title: A simple method for the isolation and purification of total lipids from animal tissues
  publication-title: J. Biol. Chem.
– volume: 24
  start-page: 1041
  year: 1974
  end-page: 1063
  ident: bib11
  article-title: Hypobetalipoproteinemia: clinical and biochemical description of a new kindred with “Friedrich's Ataxia”
  publication-title: Neurology.
– volume: 103
  start-page: 340
  year: 1967
  end-page: 352
  ident: bib8
  article-title: Lipid composition of human serum lipoproteins
  publication-title: Biochem. J.
– volume: 13
  start-page: 680
  year: 1972
  end-page: 686
  ident: bib5
  article-title: Gangliosides of human, bovine and rabbit plasma
  publication-title: J. Lipid Res.
– volume: 60
  start-page: 1105
  year: 1974
  end-page: 1111
  ident: bib23
  article-title: Human erythrocyte P and P
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 218
  start-page: 372
  year: 1970
  end-page: 375
  ident: bib3
  article-title: Occurrence of hematoside in human plasma
  publication-title: Biochim. Biophys. Acta.
– volume: 16
  start-page: 111
  year: 1973
  end-page: 151
  ident: bib14
  article-title: The proteins of plasma lipoproteins: properties and significance
  publication-title: Adv. Clin.Chem.
– start-page: 172
  year: 1969
  end-page: 232
  ident: bib4
  article-title: Lipids of the erythrocyte
  publication-title: Red Cell Membrane
– volume: 50
  start-page: 152
  year: 1957
  end-page: 161
  ident: bib17
  article-title: Micro-method for the direct determination of serum triglycerides
  publication-title: J. Lab. Clin. Med.
– volume: 276
  start-page: 32
  year: 1967
  end-page: 44
  ident: bib13
  article-title: Fat transport in lipoproteins—an integrated approach to mechanisms and disorders
  publication-title: New Engl. J. Med.
– volume: 53
  start-page: 440
  year: 1974
  end-page: 453
  ident: bib10
  article-title: A study of the abnormal lipoproteins in abetalipoproteinemia
  publication-title: J. Clin. Invest.
– volume: 52
  start-page: 1569
  year: 1973
  end-page: 1577
  ident: bib12
  article-title: Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction
  publication-title: J. Clin. Invest.
– volume: 13
  start-page: 207
  year: 1972
  end-page: 219
  ident: bib19
  article-title: Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosylhydrolase deficiency: lactosylceramidosis
  publication-title: J. Lipid Res.
– volume: 164
  start-page: 553
  year: 1969
  end-page: 555
  ident: bib6
  article-title: Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes
  publication-title: Science.
– volume: 10
  start-page: 188
  year: 1969
  end-page: 192
  ident: bib7
  article-title: Concentrations of glycosylceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosis
  publication-title: J. Lipid Res.
– volume: 44
  start-page: 576
  year: 1971
  end-page: 588
  ident: bib15
  article-title: Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low-density and high-density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins
  publication-title: Anal. Biochem.
– volume: 13
  start-page: 273
  year: 1969
  end-page: 331
  ident: bib22
  article-title: Immunochemical reactions of lipids
  publication-title: Progr. Allergy.
– volume: 245
  start-page: 410
  year: 1970
  end-page: 416
  ident: bib9
  article-title: In vivo studies on glycosphingolipid metabolism in porcine blood
  publication-title: J. Biol. Chem.
– volume: 193
  start-page: 265
  year: 1951
  end-page: 275
  ident: bib21
  article-title: Protein measurement with Folin phenol reagent
  publication-title: J. Biol. Chem.
– volume: 70
  start-page: 432
  year: 1963
  end-page: 438
  ident: bib1
  article-title: The separation of neutral blood serum glycolipid by TLC
  publication-title: Biochim. Biophys. Acta.
– start-page: 21
  year: 1975
  end-page: 38
  ident: bib24
  article-title: The chemistry of serum lipoproteins
  publication-title: International Encyclopedia of Pharmacology and Therapeutics
– start-page: 223
  year: 1973
  end-page: 246
  ident: bib25
  article-title: The structure of human serum low and high density lipoproteins
  publication-title: Atherogenesis Initiating Factors. CIBA Fdn. Symp. 12
– volume: 53
  start-page: 440
  year: 1974
  ident: 10.1016/S0022-2275(20)36996-0_bib10
  article-title: A study of the abnormal lipoproteins in abetalipoproteinemia
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI107578
– volume: 13
  start-page: 207
  year: 1972
  ident: 10.1016/S0022-2275(20)36996-0_bib19
  article-title: Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosylhydrolase deficiency: lactosylceramidosis
  publication-title: J. Lipid Res.
  doi: 10.1016/S0022-2275(20)39414-1
– start-page: 172
  year: 1969
  ident: 10.1016/S0022-2275(20)36996-0_bib4
  article-title: Lipids of the erythrocyte
– volume: 245
  start-page: 410
  year: 1970
  ident: 10.1016/S0022-2275(20)36996-0_bib9
  article-title: In vivo studies on glycosphingolipid metabolism in porcine blood
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)63406-4
– volume: 13
  start-page: 273
  year: 1969
  ident: 10.1016/S0022-2275(20)36996-0_bib22
  article-title: Immunochemical reactions of lipids
  publication-title: Progr. Allergy.
– volume: 60
  start-page: 1105
  year: 1974
  ident: 10.1016/S0022-2275(20)36996-0_bib23
  article-title: Human erythrocyte P and Pk blood group antigens: identification as glyco-sphingolipids
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/0006-291X(74)90426-4
– volume: 44
  start-page: 576
  year: 1971
  ident: 10.1016/S0022-2275(20)36996-0_bib15
  article-title: Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low-density and high-density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins
  publication-title: Anal. Biochem.
  doi: 10.1016/0003-2697(71)90247-8
– start-page: 21
  year: 1975
  ident: 10.1016/S0022-2275(20)36996-0_bib24
  article-title: The chemistry of serum lipoproteins
– volume: 103
  start-page: 340
  year: 1967
  ident: 10.1016/S0022-2275(20)36996-0_bib8
  article-title: Lipid composition of human serum lipoproteins
  publication-title: Biochem. J.
  doi: 10.1042/bj1040340
– volume: 52
  start-page: 1569
  year: 1973
  ident: 10.1016/S0022-2275(20)36996-0_bib12
  article-title: Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI107333
– volume: 276
  start-page: 32
  year: 1967
  ident: 10.1016/S0022-2275(20)36996-0_bib13
  article-title: Fat transport in lipoproteins—an integrated approach to mechanisms and disorders
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJM196702022760507
– volume: 8
  start-page: 621
  year: 1967
  ident: 10.1016/S0022-2275(20)36996-0_bib2
  article-title: Quantitative determination of the neutral glycosylceramides in human blood
  publication-title: J. Lipid Res.
  doi: 10.1016/S0022-2275(20)38884-2
– volume: 193
  start-page: 265
  year: 1951
  ident: 10.1016/S0022-2275(20)36996-0_bib21
  article-title: Protein measurement with Folin phenol reagent
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)52451-6
– volume: 24
  start-page: 1041
  year: 1974
  ident: 10.1016/S0022-2275(20)36996-0_bib11
  article-title: Hypobetalipoproteinemia: clinical and biochemical description of a new kindred with “Friedrich's Ataxia”
  publication-title: Neurology.
  doi: 10.1212/WNL.24.11.1051
– volume: 70
  start-page: 432
  year: 1963
  ident: 10.1016/S0022-2275(20)36996-0_bib1
  article-title: The separation of neutral blood serum glycolipid by TLC
  publication-title: Biochim. Biophys. Acta.
  doi: 10.1016/0006-3002(63)90773-X
– volume: 50
  start-page: 152
  year: 1957
  ident: 10.1016/S0022-2275(20)36996-0_bib17
  article-title: Micro-method for the direct determination of serum triglycerides
  publication-title: J. Lab. Clin. Med.
– start-page: 223
  year: 1973
  ident: 10.1016/S0022-2275(20)36996-0_bib25
  article-title: The structure of human serum low and high density lipoproteins
– volume: 10
  start-page: 188
  year: 1969
  ident: 10.1016/S0022-2275(20)36996-0_bib7
  article-title: Concentrations of glycosylceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosis
  publication-title: J. Lipid Res.
  doi: 10.1016/S0022-2275(20)42667-7
– volume: 234
  start-page: 466
  year: 1959
  ident: 10.1016/S0022-2275(20)36996-0_bib20
  article-title: Phosphorus assay in column chromatography
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)70226-3
– volume: 164
  start-page: 553
  year: 1969
  ident: 10.1016/S0022-2275(20)36996-0_bib6
  article-title: Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes
  publication-title: Science.
  doi: 10.1126/science.164.3879.553
– volume: 16
  start-page: 111
  year: 1973
  ident: 10.1016/S0022-2275(20)36996-0_bib14
  article-title: The proteins of plasma lipoproteins: properties and significance
  publication-title: Adv. Clin.Chem.
  doi: 10.1016/S0065-2423(08)60345-5
– volume: 21
  start-page: 255
  year: 1968
  ident: 10.1016/S0022-2275(20)36996-0_bib16
  article-title: Serum cholesterol measurement based on ethanol extraction of ferric chloride sulfuric acid
  publication-title: Clin. Chim. Acta.
  doi: 10.1016/0009-8981(68)90135-6
– volume: 226
  start-page: 497
  year: 1957
  ident: 10.1016/S0022-2275(20)36996-0_bib18
  article-title: A simple method for the isolation and purification of total lipids from animal tissues
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)64849-5
– volume: 218
  start-page: 372
  year: 1970
  ident: 10.1016/S0022-2275(20)36996-0_bib3
  article-title: Occurrence of hematoside in human plasma
  publication-title: Biochim. Biophys. Acta.
  doi: 10.1016/0005-2760(70)90159-1
– volume: 13
  start-page: 680
  year: 1972
  ident: 10.1016/S0022-2275(20)36996-0_bib5
  article-title: Gangliosides of human, bovine and rabbit plasma
  publication-title: J. Lipid Res.
  doi: 10.1016/S0022-2275(20)39374-3
SSID ssj0014461
Score 1.3298141
Snippet Five glycosphingolipids (GSL), glucosylceramide, lactosylceramide, trihexosylceramide, globoside, and hematoside (GM3) were studied in serum from normal human...
SourceID doaj
proquest
pubmed
crossref
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 125
SubjectTerms abetalipoproteinemia
Abetalipoproteinemia - blood
Adolescent
Adult
Child
familial hypercholesterolemia
Female
gas-liquid chromatography
Glycosphingolipids - blood
Humans
Hypercholesterolemia - blood
Hypercholesterolemia - genetics
Hyperlipidemias - blood
hypobetalipoproteinemia
Lipid Metabolism, Inborn Errors - blood
Lipoproteins - blood
Lipoproteins, HDL - blood
Lipoproteins, LDL - blood
Lipoproteins, VLDL - blood
Male
mixed hyperlipoproteinemias
serum glycosphingolipids
Sex Factors
Tangier disease
Title Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias
URI https://dx.doi.org/10.1016/S0022-2275(20)36996-0
https://www.ncbi.nlm.nih.gov/pubmed/178813
https://www.proquest.com/docview/83425201
https://doaj.org/article/295120ed01a9483181e5e153766da4f8
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQOcAFQVvE8ig-IASHgONHnD0uhaqiggOiojfLiW0aaeusSPewR_45M47TpQe0F26WZTuJZ5z5xh5_Q8iruedCBakKAQpTSLBJRR0seCmNEAHMh3YeT3S_fK1Oz-XnC3XxV6ovjAkb6YHHiXvPAQJw5h0r7VzWMGDplS-RhKRyVoZ0zRds3uRM5fMDcHLKiSecc622d3fwbnCufMPZW1GlKNxbVimR998yTv8Cn8kInTwkDzJ6pIvxrR-ROz7uk4NFBM_5akNf0xTPmTbK98m94ymX2wH5_RELObUV7QP9udy0_bDC7ad-2a06N9AuUgCDFFRyfUWhrk8UDl0csH1EaLukKaMfHdYN7t4M1EZHMzHrQHFHl15uVn2R6qGETFpjAlo7HJLzk0_fj0-LnHyhaCVMeKG0ZE4CHgsa-SQlJjmqHKxuB0JUjtdBg_BLq1ijWs2s50HbKrSi1pYFgI2PyV7so39CKFLECfBLXKOsdLqcWzGvaqaU843lvJkROU2-aTMzOSbIWJptCBrIzKDMDGcmycywGXl30201UnPs6vABJXvTGJm1UwXom8n6Znbp24zUk16YDFJG8AFDdbue_3LSIwPyx5MZG32_Hkwt4NcJUGxGDkf12n4Q0v2Lp__jzZ-R-yWAzzGA7jnZu_619i8AUV03R-Tu4uzbj7OjtIj-ALLeF7c
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+of+glycosphingolipids+in+the+serum+lipoproteins+of+normal+human+subjects+and+patients+with+hypo-+and+hyperlipidemias&rft.jtitle=Journal+of+lipid+research&rft.au=Dawson%2C+G&rft.au=Kruski%2C+A+W&rft.au=Scanu%2C+A+M&rft.date=1976-03-01&rft.issn=0022-2275&rft.volume=17&rft.issue=2&rft.spage=125&rft.epage=131&rft_id=info:doi/10.1016%2FS0022-2275%2820%2936996-0&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S0022_2275_20_36996_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2275&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2275&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2275&client=summon